LEXINGTON, Massachusetts, September 6, 2013 /PRNewswire/ --
Shire's Chief Executive Officer, Flemming Ornskov, MD will present at the Morgan Stanley Global Healthcare Conference Monday, September 9 th, 2013 at 3:50 PM EDT/ 20:50 BST. Investors may access a live audio webcast of the presentation at http://www.shire.com/shireplc/en/investors.
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas. http://www.shire.com For further information please contact: Investor Relations Eric Rojas firstname.lastname@example.org +1-781-482-0999 Sarah Elton-Farr email@example.com +44(0)1256-894157 SOURCE Shire plc